MYH14 and cardiomyopathy: It has been proposed that cardiomyopathy associated mutations in myosin and thick filament associated proteins could disrupt contractile properties by altering the formation of the SRX, which ultimately impacts the number of cross-bridges capable of generating force (Kampourakis et al., 2016).